Engineering next-generation RNA therapeutics inspired by extracellular vesicles
Our research aims not only to advance fundamental knowledge but also to translate scientific discoveries into innovative therapeutic technologies with potential clinical impact.
NFAT3-expressing extracellular vesicles for therapeutic applications
Patent: US11154598B2
Status: Granted ✅
Applicants
INSERM
Université Paris Cité
ERGANEO
Inventors
Sébastien Jauliac
Livia Camargo
Summary
Therapeutic use of extracellular vesicles derived from NFAT3-expressing cells for the treatment of cancer.
Combinatorial RNA therapeutic compositions
Patent: US20240084300A1
Status: Patent application
Applicants
INSERM
Université Paris Cité
ERGANEO
Summary
Combinatorial regulatory RNA compositions designed to target complex cancer signaling networks.
Translation to the Clinic
We actively collaborate with academic and industrial partners to accelerate the development of innovative RNA-based therapeutic strategies.